<p>泰格医药 (03347.HK) +0.280 (+0.777%) 空头头寸 $21.04M; 比率 8.028% 宣布计划在 12 个月内使用自有资金或自筹资金，通过集中竞价交易回购部分 A 股。回购的股份将用于后续实施 A 股股权激励计划或 A 股员工持股计划，以及减少公司的注册资本。总回购金额不低于人民币 5 亿元且不超过人民币 10 亿元，回购价格不超过人民币 60 元每股。(ha/u)(香港股票报价延迟至少 15 分钟。空头数据截至 2026-05-13 16:25.)</p>

泰格医药

<p>泰格医药宣布计划在 12 个月内回购价值在 5 亿至 10 亿人民币之间的 A 股。此次回购将通过其自有资金或自筹资金通过集中竞价交易进行。回购的股份将用于 A 股股权激励计划、员工持股计划，以及减少注册资本，回购价格最高为每股 60 人民币</p>

<p>TIGERMED (03347.HK) +0.280 (+0.777%)  Short selling $21.04M; Ratio 8.028%  announced that it plans to use its own funds or self-raised funds within 12 months to repurchase part of its A shares through centralized bidding transactions. The repurchased shares will be used for the subsequent implementation of A-share equity incentive schemes or A-share employee share ownership plans, as well as to reduce the companys registered capital. The total repurchase amount will be no less than RMB500 million and no more than RMB1 billion, with the repurchase price not exceeding RMB60 per share. (ha/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)</p>
<div class="lb-trans"><p>泰格医药 (03347.HK) +0.280 (+0.777%) 空头头寸 $21.04M; 比率 8.028% 宣布计划在 12 个月内使用自有资金或自筹资金，通过集中竞价交易回购部分 A 股。回购的股份将用于后续实施 A 股股权激励计划或 A 股员工持股计划，以及减少公司的注册资本。总回购金额不低于人民币 5 亿元且不超过人民币 10 亿元，回购价格不超过人民币 60 元每股。(ha/u)(香港股票报价延迟至少 15 分钟。空头数据截至 2026-05-13 16:25.)</p>
</div>

泰格医药计划最多花费人民币 10 亿元用于回购 A 股